Consegna Pharma Inc.
PrivateLast Round
Grant
Sep 15, 2023
Total Funding Raised
$3.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Consegna Pharma Inc. is a biopharmaceutical company that develops long-acting injectable medications by reformulating known, FDA-approved drugs to improve clinical outcomes and patient adherence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Consegna Pharma Inc. Comparables
Compare Consegna Pharma Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elysium Therapeutics | 85% | |
| Trekka Therapeutics, Inc. | 77% | |
| Braeburn Inc. | 73% |
Consegna Pharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 15, 2023 | ||||
| Grant | Sep 30, 2022 | ||||
| Grant | Nov 19, 2019 |
Consegna Pharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| University of Pittsburgh Innovation Institute | Accelerator |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 228% MoM.
- Jul 25, 2026
Monthly visitors increased 235% MoM, from 65 to 218.
Consegna Pharma Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Consegna Pharma Inc.'s valuation, stock price, and market status.
Is Consegna Pharma Inc. a public or private company?
Consegna Pharma Inc. is a private company.
What is the current stock price of Consegna Pharma Inc.?
Consegna Pharma Inc. is a private company with no public stock price. Caplight tracks Consegna Pharma Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Consegna Pharma Inc. worth (valuation)?
Valuation information for Consegna Pharma Inc. is not publicly available.
Can I buy Consegna Pharma Inc. stock?
Consegna Pharma Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Consegna Pharma Inc.'s last funding round?
Consegna Pharma Inc.'s most recent funding round was Grant on September 15, 2023.
Who are the main investors in Consegna Pharma Inc.?
Key investors in Consegna Pharma Inc. include National Institute on Drug Abuse, University of Pittsburgh Innovation Institute, National Institutes of Health (NIH).
Will Consegna Pharma Inc. IPO soon?
No public IPO plans have been announced for Consegna Pharma Inc..
How can I track Consegna Pharma Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Consegna Pharma Inc.'s secondary market activity and sign up for updates.